Ashish Manne· @AshishManne · X·· 2026-04-21Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
From translational work yesterday to future-focused approaches today at #AACR26.
Our AI model uses routine pathology slides help connect what we see under the microscope to patient outcomes and potential treatment decisions.
#PancreaticCancer #AI
@OSUCCC_James
@OhioStateMedOnc
Heat 2 · 2 likes · 0 replies · 0 reposts
Source: Ashish Manne · x.com